Aiforia Technologies
3.57
EUR
-2.19 %
1,866 following
AIFORIA
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Income statement
Valuation
Quarterly estimates
Income statement
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.3 | 0.6 | 0.8 | 1.0 | 1.6 | 2.4 | 2.9 | 4.7 | 7.6 | 12.5 | 20.0 |
growth-% | 134.9 % | 32.9 % | 14.7 % | 64.9 % | 49.3 % | 18.9 % | 65.7 % | 60.0 % | 65.0 % | 60.8 % | |
EBITDA | -1.5 | -2.1 | -1.6 | -3.5 | -9.5 | -9.7 | -8.2 | -7.1 | -5.8 | -2.6 | 2.9 |
EBIT (adj.) | -2.1 | -3.0 | -2.6 | -4.7 | -11.8 | -12.9 | -12.2 | -11.9 | -12.0 | -8.9 | -2.6 |
EBIT | -2.1 | -3.0 | -2.6 | -4.7 | -11.8 | -12.9 | -12.2 | -11.9 | -12.0 | -8.9 | -2.6 |
Profit before taxes | -2.1 | -3.1 | -2.8 | -7.6 | -12.2 | -12.9 | -11.9 | -12.0 | -12.3 | -9.2 | -2.9 |
Net income | -2.1 | -3.1 | -2.8 | -7.6 | -12.2 | -12.9 | -11.9 | -12.0 | -12.3 | -9.2 | -2.9 |
EPS (adj.) | -0.15 | -0.14 | -0.29 | -0.47 | -0.50 | -0.41 | -0.36 | -0.36 | -0.27 | -0.09 | |
growth-% | |||||||||||
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend ratio |
Profitability and return on capital
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | -551.1 % | -335.1 % | -189.8 % | -354.2 % | -593.3 % | -404.5 % | -288.4 % | -150.0 % | -76.3 % | -21.0 % | 14.5 % |
EBIT-% (adj.) | -764.7 % | -472.9 % | -310.1 % | -481.4 % | -731.9 % | -537.1 % | -427.8 % | -252.9 % | -158.1 % | -71.6 % | -12.9 % |
EBIT-% | -764.7 % | -472.9 % | -310.1 % | -481.4 % | -731.9 % | -537.1 % | -427.8 % | -252.9 % | -158.1 % | -71.6 % | -12.9 % |
ROE | -147.6 % | -386.3 % | -39.0 % | -36.2 % | -54.8 % | -69.3 % | -66.7 % | -91.4 % | -347.0 % | 84.8 % | |
ROI | -78.9 % | -77.0 % | -20.9 % | -31.8 % | -45.4 % | -52.0 % | -56.0 % | -64.0 % | -51.7 % | -17.1 % |